白塞病中HLA - B5的高患病率。
The high prevalence of HLA-B5 in Behçet's disease.
作者信息
Yazici H, Akokan G, Yalçin B, Müftüoğlu A
出版信息
Clin Exp Immunol. 1977 Nov;30(2):259-61.
Abstract
Sixteen of the nineteen (84%) patients with Behçet's disease in Turkey had HLA-B5; the prevalence of HLA-B5 among 150 controls was 27%.
摘要
在土耳其，19名白塞病患者中有16名（84%）携带HLA - B5；150名对照者中HLA - B5的患病率为27%。
相似文献
1
The high prevalence of HLA-B5 in Behçet's disease.白塞病中HLA - B5的高患病率。
Clin Exp Immunol. 1977 Nov;30(2):259-61.
2
The prevalence of Behçet's syndrome in a rural area in northern Turkey.土耳其北部某农村地区白塞病的患病率。
J Rheumatol. 1988;15(5):820-2.
3
[The relationship of the HLA antigen system to Behçet's disease].
Vestn Dermatol Venerol. 1990(5):55-7.
4
Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
J Rheumatol. 1981 Mar-Apr;8(2):325-7.
5
[The prevalence of HLA-B5 antigen in Behçet's disease].
Nouv Presse Med. 1978 Oct 21;7(36):3263.
6
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.在土耳其，HLA - B5与针刺反应试验联合应用作为白塞病的诊断标志物。
J Rheumatol. 1980 Mar-Apr;7(2):206-10.
7
[HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].[对德国裔复发性良性口疮患者和白塞病患者进行的人类白细胞抗原分型]
Z Hautkr. 1984 Aug 1;59(15):1005-9.
8
The histocompatibility antigens in patients with Behçet's disease.
Acta Derm Venereol. 1977;57(3):243-5.
9
Familial Behçet's disease.家族性白塞病。
Eur J Med. 1992 Nov;1(7):391-5.
10
High HL-A5 frequency in Behçet's disease.白塞病中HL-A5抗原频率较高。
Hokkaido Igaku Zasshi. 1976 Mar;51(2):117-21.
引用本文的文献
1
MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet's disease patients.miRNA-146a 的表达和 Behcet 病患者中 miRNA-146a rs2910164 多态性。
Clin Rheumatol. 2019 Feb;38(2):397-402. doi: 10.1007/s10067-018-4191-2. Epub 2018 Jul 10.
2
Role of genetics in pediatric rheumatology.遗传学在儿童风湿病学中的作用。
Turk Pediatri Ars. 2017 Sep 1;52(3):113-121. doi: 10.5152/TurkPediatriArs.2017.4953. eCollection 2017 Sep.
3
Update on the diagnosis and management of Behçet's disease.白塞病诊断与管理的最新进展
Open Access Rheumatol. 2014 Dec 30;7:1-8. doi: 10.2147/OARRR.S46644. eCollection 2015.
4
Behçet's disease physiopathology: a contemporary review.白塞病的病理生理学：当代综述。
Auto Immun Highlights. 2016 Dec;7(1):4. doi: 10.1007/s13317-016-0074-1. Epub 2016 Feb 12.
5
Neuro-Behçet's disease: a report of sixteen patients.神经白塞病：16 例患者报告。
Neuropsychiatr Dis Treat. 2010 May 25;6:219-25.
6
Spectrum of Behçet's disease in the Indian population.印度人群中的白塞病谱系
Int Ophthalmol. 2009 Dec;29(6):495-501. doi: 10.1007/s10792-008-9273-8. Epub 2008 Oct 21.
7
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.用与霍乱毒素B亚基相连的336 - 351肽进行口服耐受诱导以预防白塞病葡萄膜炎复发
Clin Exp Immunol. 2004 Jul;137(1):201-8. doi: 10.1111/j.1365-2249.2004.02520.x.
8
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.白塞病：感染病因、新自身抗原与HLA - B51
Ann Rheum Dis. 2001 Nov;60(11):996-1002. doi: 10.1136/ard.60.11.996.
9
CNS involvement in neuro-Behçet syndrome: an MR study.中枢神经系统受累于神经白塞病综合征：一项磁共振成像研究。
AJNR Am J Neuroradiol. 1999 Jun-Jul;20(6):1015-24.
10
Pulmonary vasculitis: classification, clinical features, and management.肺血管炎：分类、临床特征及管理
Clin Rev Allergy Immunol. 1997 Spring;15(1):73-95. doi: 10.1007/BF02828279.
本文引用的文献
1
MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.人血清细胞毒素的微滴分析法
Nature. 1964 Dec 5;204:998-1000. doi: 10.1038/204998b0.
2
Behçet's syndrome with arthritis.伴有关节炎的白塞病
Ann Rheum Dis. 1969 Mar;28(2):95-103. doi: 10.1136/ard.28.2.95.
3
Behçet's disease. Report of 10 cases, 3 with new manifestations.白塞病。10例报告，3例有新表现。
Ann Intern Med. 1971 Oct;75(4):561-70. doi: 10.7326/0003-4819-75-4-561.
4
Behçet's disease.白塞病
Ann Intern Med. 1972 Feb;76(2):332-3. doi: 10.7326/0003-4819-76-2-332.
5
Specific histocompatibility antigens associated with Behçet's disease.与白塞病相关的特异性组织相容性抗原。
Am J Ophthalmol. 1975 Oct;80(4):636-41. doi: 10.1016/0002-9394(75)90394-3.
6
HLA in Behçet's disease.
Lancet. 1976 Mar 27;1(7961):694. doi: 10.1016/s0140-6736(76)92809-9.
Zotero 插件